129 related articles for article (PubMed ID: 17524311)
1. [Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant].
Sánchez-Salmón A; Barandela J; Garrido M; Ciobotaru AB; Albo C; Ruibal A
Rev Esp Med Nucl; 2007; 26(3):165-8. PubMed ID: 17524311
[TBL] [Abstract][Full Text] [Related]
2. Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma.
Fallanca F; Picchio M; Crivellaro C; Mapelli P; Samanes Gajate AM; Sabattini E; Gianolli L; Messa C
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):207-9. PubMed ID: 22980128
[TBL] [Abstract][Full Text] [Related]
3. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Weihrauch MR; Re D; Scheidhauer K; Ansén S; Dietlein M; Bischoff S; Bohlen H; Wolf J; Schicha H; Diehl V; Tesch H
Blood; 2001 Nov; 98(10):2930-4. PubMed ID: 11698273
[TBL] [Abstract][Full Text] [Related]
4. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
[TBL] [Abstract][Full Text] [Related]
5. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
[TBL] [Abstract][Full Text] [Related]
6. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
[TBL] [Abstract][Full Text] [Related]
7. [Controversial aspects in the current treatment of Hodgkin's disease].
Vicente J
Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
[No Abstract] [Full Text] [Related]
8. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Longo DL
Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
[No Abstract] [Full Text] [Related]
9. Significance of mediastinal involvement in early Hodgkin's disease.
Zucali R; Zanini M; Banfi A
Hematol Oncol; 1984; 2(1):72-4. PubMed ID: 6203823
[No Abstract] [Full Text] [Related]
10. Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
Girinsky T; Aupérin A; Ribrag V; Elleuch M; Fermé C; Bonniaud G; Ruelle C; Alberini JL; Celebic A; Edeline V
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1047-1052. PubMed ID: 25035208
[TBL] [Abstract][Full Text] [Related]
11. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Suon SZ
Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
[No Abstract] [Full Text] [Related]
12. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Qiao W; Zhao J; Wang C; Wang T; Xing Y
Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
[TBL] [Abstract][Full Text] [Related]
13. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
[No Abstract] [Full Text] [Related]
14. Autologous bone marrow transplantation in Hodgkin's disease.
Dumont J; Teillet F
Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):531-8. PubMed ID: 2419958
[No Abstract] [Full Text] [Related]
15. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
16. Conventional salvage therapy for Hodgkin's lymphoma.
Pfreundschuh M; Schaadt M; Diehl V
Recent Results Cancer Res; 1989; 117():225-32. PubMed ID: 2481331
[No Abstract] [Full Text] [Related]
17. Treatment for localized Hodgkin's disease.
Crowther D
Hematol Oncol; 1984; 2(1):63-6. PubMed ID: 6203822
[No Abstract] [Full Text] [Related]
18. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
19. Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Rosenberg SA
Scand J Haematol; 1985 Apr; 34(4):289-92. PubMed ID: 2408324
[No Abstract] [Full Text] [Related]
20. [Controversy regarding the treatment of Hodgkin's disease].
Balwierz W; Armata J
Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
